Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites.

Li S, Gao Y, Tokuyama T, Yamamoto J, Yokota N, Yamamoto S, Terakawa S, Kitagawa M, Namba H.

Cancer Lett. 2007 Jun 28;251(2):220-7. Epub 2006 Dec 28.

PMID:
17196326
2.

Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.

Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N, Namba H.

Cancer Gene Ther. 2005 Jul;12(7):600-7.

PMID:
15775995
3.

Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene.

Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N, Namba H.

Oncology. 2005;69(6):503-8. Epub 2006 Jan 16.

PMID:
16424680
4.
5.

Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy.

Amano S, Li S, Gu C, Gao Y, Koizumi S, Yamamoto S, Terakawa S, Namba H.

Int J Oncol. 2009 Dec;35(6):1265-70.

PMID:
19885548
6.

Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.

Berenstein M, Adris S, Ledda F, Wolfmann C, Medina J, Bravo A, Mordoh J, Chernajovsky Y, Podhajcer OL.

Cancer Gene Ther. 1999 Jul-Aug;6(4):358-66.

7.

The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells.

Huang Q, Liu XZ, Kang CS, Wang GX, Zhong Y, Pu PY.

Cancer Gene Ther. 2010 Mar;17(3):192-202. doi: 10.1038/cgt.2009.64. Epub 2009 Oct 23.

PMID:
19851353
8.

[Antitumor gene therapy using suicide genes].

Berenstein M, Adris S, Ledda F, Wolfmann C, Medina J, Bravo A, Mordoh J, Chernajovsky Y, Podhajcer OL.

Medicina (B Aires). 1998;58(2):185-8. Spanish.

PMID:
9706253
9.

Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging.

Maron A, Gustin T, Le Roux A, Mottet I, Dedieu JF, Brion JP, Demeure R, Perricaudet M, Octave JN.

Gene Ther. 1996 Apr;3(4):315-22.

PMID:
8732163
10.

Timing of ganciclovir administration in glioma gene therapy using HSVtk gene-transduced mesenchymal stem cells.

Amano S, Gu C, Koizumi S, Tokuyama T, Namba H.

Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):245-50.

PMID:
21980039
11.
12.

Tumoricidal bystander effect in the suicide gene therapy using mesenchymal stem cells does not injure normal brain tissues.

Amano S, Gu C, Koizumi S, Tokuyama T, Namba H.

Cancer Lett. 2011 Jul 1;306(1):99-105. doi: 10.1016/j.canlet.2011.02.037. Epub 2011 Mar 29.

PMID:
21450400
13.
14.

Therapeutic effect of genetically engineered mesenchymal stem cells in rat experimental leptomeningeal glioma model.

Gu C, Li S, Tokuyama T, Yokota N, Namba H.

Cancer Lett. 2010 May 28;291(2):256-62. doi: 10.1016/j.canlet.2009.10.020. Epub 2009 Nov 27.

PMID:
19945214
15.

Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment.

Sandmair AM, Loimas S, Poptani H, Vainio P, Vanninen R, Turunen M, Tyynelä K, Vapalahti M, Ylä-Herttuala S.

Acta Neurochir (Wien). 1999;141(8):867-72; discussion 872-3.

PMID:
10536724
16.

Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells.

Huang Q, Pu P, Xia Z, You Y.

J Neurooncol. 2007 May;82(3):239-48. Epub 2006 Nov 11.

PMID:
17102907
17.

Treatment of rat gliomas with recombinant retrovirus harboring Herpes simplex virus thymidine kinase suicide gene.

Hlavatý J, Hlubinová K, Altanerová V, Líska J, Altaner C.

Neoplasma. 1997;44(6):342-7.

PMID:
9605005
18.

Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.

Miletic H, Fischer YH, Giroglou T, Rueger MA, Winkeler A, Li H, Himmelreich U, Stenzel W, Jacobs AH, von Laer D.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6761-8.

19.

Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.

Herrlinger U, Woiciechowski C, Sena-Esteves M, Aboody KS, Jacobs AH, Rainov NG, Snyder EY, Breakefield XO.

Mol Ther. 2000 Apr;1(4):347-57.

20.

Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.

Saleh M, Wiegmans A, Malone Q, Stylli SS, Kaye AH.

J Natl Cancer Inst. 1999 Mar 3;91(5):438-45.

PMID:
10070943

Supplemental Content

Support Center